Plan ADC distribution imaging and efficacy readouts, with optional whole-organoid imaging or quantitative penetration analysis.
STUDY EVIDENCE
Start with target and model selection, then combine section-level spatial distribution, post-treatment morphology and dose response; add dedicated imaging and quantification when the study needs an intact-organoid view of penetration.
Choose models from candidate format, target and tissue context, then combine spatial distribution, morphology, viability and dose response, with mechanism or normal-tissue safety studies added as needed.
Organizes imaging, efficacy and follow-up validation into one connected study plan
Brings together frozen-section distribution data and complementary PDO morphology and dose-response data to show how imaging and functional endpoints work together in an ADC program.
Guides molecular-format, imaging, dose-window and candidate-comparison planningTarget expression, tissue architecture and candidate mechanism jointly determine the model and controls.
Frozen-section images of labeled antibodies or nanobodies show relative distribution. Intact-organoid penetration depth requires a separate imaging and quantification design.
For the candidate, choose viability, apoptosis or bystander-effect endpoints and analyze activity separately from distribution imaging.
Raw imaging, quantitative outputs, analysis methods and a study report are delivered with the labels, doses and time points specified in the study plan.
Related models and services
PROJECT DISCUSSION
Share your project goal and available materials. Our scientists will recommend models, controls, assays and a practical first study.
